Alex Thompson
Stock Analyst at Stifel
(1.06)
# 3,559
Out of 4,735 analysts
30
Total ratings
41.67%
Success rate
-10.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Thompson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintains: Buy | $200 → $207 | $131.06 | +57.94% | 2 | Nov 15, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $49 | $12.98 | +277.50% | 1 | Oct 11, 2024 | |
| ARGX argenx SE | Maintains: Buy | $485 → $500 | $647.39 | -22.77% | 4 | Jun 24, 2024 | |
| THRD Third Harmonic Bio | Initiates: Buy | $23 | $6.00 | +283.33% | 1 | Jun 18, 2024 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $36 → $54 | $22.28 | +142.37% | 2 | Mar 26, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $44 | $21.66 | +103.14% | 1 | Feb 15, 2024 | |
| VTYX Ventyx Biosciences | Maintains: Hold | $6 → $2 | $2.08 | -3.85% | 5 | Dec 18, 2023 | |
| TVTX Travere Therapeutics | Maintains: Hold | $8 → $10 | $19.46 | -48.61% | 2 | Dec 18, 2023 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $66 → $69 | $45.82 | +50.59% | 2 | Dec 18, 2023 | |
| ACRS Aclaris Therapeutics | Maintains: Hold | $2 → $1 | $2.60 | -61.54% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $18.41 | +117.27% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $1.20 | +3,233.33% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $34 | $23.59 | +44.13% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $11.07 | +198.10% | 1 | Dec 14, 2022 |
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $200 → $207
Current: $131.06
Upside: +57.94%
Oruka Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $49
Current: $12.98
Upside: +277.50%
argenx SE
Jun 24, 2024
Maintains: Buy
Price Target: $485 → $500
Current: $647.39
Upside: -22.77%
Third Harmonic Bio
Jun 18, 2024
Initiates: Buy
Price Target: $23
Current: $6.00
Upside: +283.33%
Spyre Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $22.28
Upside: +142.37%
Dianthus Therapeutics
Feb 15, 2024
Initiates: Buy
Price Target: $44
Current: $21.66
Upside: +103.14%
Ventyx Biosciences
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $2.08
Upside: -3.85%
Travere Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $8 → $10
Current: $19.46
Upside: -48.61%
MoonLake Immunotherapeutics
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $45.82
Upside: +50.59%
Aclaris Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $2.60
Upside: -61.54%
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $18.41
Upside: +117.27%
Aug 9, 2023
Initiates: Buy
Price Target: $40
Current: $1.20
Upside: +3,233.33%
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $23.59
Upside: +44.13%
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $11.07
Upside: +198.10%